These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16736423)

  • 21. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
    Aggarwal N; Batwara R; McCarthy ET; Sharma R; Sharma M; Savin VJ
    Am J Kidney Dis; 2007 Nov; 50(5):826-9. PubMed ID: 17954296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presumed recurrence of intracranial Rosai-Dorfman disease as a cervical spine tumor.
    Seyednejad F; Tubbs RS; Shoja MM; Daghigi MH; Oakes WJ
    Acta Neurochir (Wien); 2007; 149(4):425-7. PubMed ID: 17380248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of histiocytic lymphophagocytic panniculitis (Rosai-Dorfman disease) with positive autoantibodies.
    Wang F; Chen X; Wu W; Wang Z; Han J
    J Dtsch Dermatol Ges; 2015 Apr; 13(4):334-6. PubMed ID: 25819246
    [No Abstract]   [Full Text] [Related]  

  • 24. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome].
    Shimizu H; Saitoh T; Osaki Y; Yamane A; Gohda F; Irisawa H; Yokohama A; Uchiumi H; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
    Rinsho Ketsueki; 2007 Jun; 48(6):514-7. PubMed ID: 17633102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of a second course of cyclophosphamide therapy in children with frequently relapsing nephrotic syndrome after cyclosporin A therapy.
    Kano K; Nishikura K; Hoshi M; Yamada Y; Arisaka O
    Clin Nephrol; 2001 May; 55(5):424-5. PubMed ID: 11393392
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
    J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapy.
    Gebhardt C; Averbeck M; Paasch U; Ugurel S; Kurzen H; Stumpp P; Simon JC; Treudler R
    Arch Dermatol; 2009 May; 145(5):571-4. PubMed ID: 19451502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
    Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
    Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.
    Li X; Hong Y; An Q; Chen J; Wei H; Chen HD; Gao XH
    JAMA Dermatol; 2013 Aug; 149(8):992-3. PubMed ID: 23783880
    [No Abstract]   [Full Text] [Related]  

  • 31. Rosai Dorfman disease--a clinico-pathological presentation.
    Mehrotra S; Ather S; Gupta P; Mehrotra B
    J Assoc Physicians India; 2007 Aug; 55():587-9. PubMed ID: 18019802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.
    Elhence R; Gulati S; Kher V; Gupta A; Sharma RK
    Pediatr Nephrol; 1994 Feb; 8(1):1-3. PubMed ID: 8142205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dapsone as a potential treatment for cutaneous Rosai-Dorfman disease with neutrophilic predominance.
    Chan CC; Chu CY
    Arch Dermatol; 2006 Apr; 142(4):428-30. PubMed ID: 16618860
    [No Abstract]   [Full Text] [Related]  

  • 34. Minimal change nephrotic syndrome.
    Almeida AF; Chafekar DS
    J Assoc Physicians India; 1993 May; 41(5):257-8. PubMed ID: 8300452
    [No Abstract]   [Full Text] [Related]  

  • 35. The pathogenesis of minimal change nephropathy.
    Mallick NP
    Clin Nephrol; 1977 Mar; 7(3):87-95. PubMed ID: 322900
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) by fine needle aspiration cytology.
    Kumar B; Karki S; Paudyal P
    Diagn Cytopathol; 2008 Oct; 36(10):691-5. PubMed ID: 18773449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine-needle aspiration cytology of Rosai-Dorfman disease of bone.
    Jing X; McHugh JB; Pu RT
    Diagn Cytopathol; 2008 Jul; 36(7):516-8. PubMed ID: 18528889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
    J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between plasma IgE and IgA in infant nephrosis and nephrotic syndrome].
    Guerra A; Cappellini T; Chiossi C; Bonvini G; Lalla M; Genova R
    Pediatr Med Chir; 1982; 4(4):425-34. PubMed ID: 7170216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
    Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A
    Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.